Olema Pharmaceuticals, Inc. (OLMA)
6.99
-0.34
(-4.64%)
USD |
NASDAQ |
Oct 30, 16:00
6.99
0.00 (0.00%)
After-Hours: 19:59
Olema Pharmaceuticals Total Return Level : 7.33 for Oct. 29, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 29, 2026 | 7.33 |
| October 28, 2026 | 7.49 |
| October 27, 2026 | 7.04 |
| October 26, 2026 | 6.62 |
| October 23, 2026 | 6.41 |
| October 22, 2026 | 7.02 |
| October 21, 2026 | 7.05 |
| October 20, 2026 | 7.25 |
| October 19, 2026 | 7.11 |
| October 16, 2026 | 6.58 |
| October 15, 2026 | 6.87 |
| October 14, 2026 | 6.80 |
| October 13, 2026 | 7.02 |
| October 12, 2026 | 7.36 |
| October 09, 2026 | 7.82 |
| October 08, 2026 | 7.82 |
| October 07, 2026 | 7.94 |
| October 06, 2026 | 7.92 |
| October 05, 2026 | 8.25 |
| October 02, 2026 | 8.225 |
| October 01, 2026 | 8.27 |
| September 30, 2026 | 8.64 |
| September 29, 2026 | 8.54 |
| September 28, 2026 | 8.61 |
| September 25, 2026 | 8.75 |
| Date | Value |
|---|---|
| September 24, 2026 | 9.04 |
| September 23, 2026 | 8.83 |
| September 22, 2026 | 9.64 |
| September 21, 2026 | 9.63 |
| September 18, 2026 | 9.82 |
| September 17, 2026 | 9.90 |
| September 16, 2026 | 9.73 |
| September 15, 2026 | 9.78 |
| September 14, 2026 | 10.29 |
| September 11, 2026 | 10.22 |
| September 10, 2026 | 10.69 |
| September 09, 2026 | 10.36 |
| September 08, 2026 | 10.98 |
| September 04, 2026 | 10.75 |
| September 03, 2026 | 10.73 |
| September 02, 2026 | 10.83 |
| September 01, 2026 | 10.56 |
| August 31, 2026 | 10.43 |
| August 28, 2026 | 10.27 |
| August 27, 2026 | 10.79 |
| August 26, 2026 | 10.85 |
| August 25, 2026 | 10.91 |
| August 24, 2026 | 10.43 |
| August 21, 2026 | 10.69 |
| August 20, 2026 | 10.90 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Puma Biotechnology, Inc. | 10.54 |
| SELLAS Life Sciences Group, Inc. | 10.16 |
| ACADIA Pharmaceuticals, Inc. | 20.76 |
| Alnylam Pharmaceuticals, Inc. | 174.00 |
| Anika Therapeutics, Inc. | 21.79 |